Trends and outcomes of mechanical circulatory support with transcatheter aortic valve replacement and transcatheter edge-to-edge repair of the mitral valve from the National Inpatient Sample, 2018 to 2021.
Document Type
Article
Publication Date
12-9-2026
Publication Title
Proceedings (Baylor University. Medical Center)
Abstract
BACKGROUND: The use of mechanical circulatory support (MCS) devices with transcatheter aortic valve replacement (TAVR) and mitral transcatheter edge-to-edge repair (mTEER) is occasionally required; however, outcomes data are lacking.
METHODS: We utilized the Nationwide Inpatient Sample database to identify hospital admissions of adults treated with TAVR and mTEER, with or without MCS, between 2018 and 2021.
RESULTS: We identified 330,055 patients undergoing TAVR and mTEER, with 3240 in the MCS group and 326,815 in the non-MCS group. From 2018 to 2021, there was a steady increase in procedural volume (
CONCLUSION: The use of MCS in patients undergoing TAVR or mTEER was associated with higher mortality, morbidity, and healthcare utilization; however, causation cannot be determined given the inherent limitations of the dataset.
Volume
39
Issue
2
First Page
239
Last Page
246
Recommended Citation
Ghoneem A, Elkholy M, Abdelhai OS, Altarawneh T, Maligireddy A, Goel M, et al [Hanson ID, Abbas AE, Jabri A] Trends and outcomes of mechanical circulatory support with transcatheter aortic valve replacement and transcatheter edge-to-edge repair of the mitral valve from the National Inpatient Sample, 2018 to 2021. Proc (Bayl Univ Med Cent). 2025 Dec 9;39(2):239-246. doi: 10.1080/08998280.2025.2592169. PMID: 41717364
DOI
10.1080/08998280.2025.2592169
ISSN
0899-8280
PubMed ID
41717364